United States v. Betsy Hillis

656 F. App'x 222
CourtCourt of Appeals for the Sixth Circuit
DecidedAugust 16, 2016
Docket14-6533
StatusUnpublished
Cited by2 cases

This text of 656 F. App'x 222 (United States v. Betsy Hillis) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Betsy Hillis, 656 F. App'x 222 (6th Cir. 2016).

Opinion

HELENE N. WHITE, Circuit Judge.

Betsy Hillis was convicted of conspiracy to manufacture methamphetamine and conspiracy to possess and distribute pseu-doephedrine with cause to believe the pseudoephedrine would be used to manufacture methamphetamine. Over Hillis’s objection at trial, the government introduced pharmacy records identifying Hillis as the purchaser of pseudoephedrine. Hil-lis now appeals, arguing (1) the- pharmacy records constituted inadmissible hearsay and their admission violated her right of confrontation, and (2) the government presented insufficient evidence of her guilt. We AFFIRM.

I..

Hillis was charged in a superseding indictment with conspiracy to manufacture and distribute 50 grams or more of actual methamphetamine or 500 grams or more of a mixture and substance containing methamphetamine, in violation of 21 U.S.C. §§ 841(a)(1), 841(b)(1)(A), and 846 (Count One); and conspiracy to possess and distribute pseudoephedrine with cause to believe it would be used to manufacture methamphetamine, in violation of 21 U.S.C. §§ 841(c)(2) and 846 (Count Two). A second superseding indictment added charges of obstructing an official proceeding (Count Three), and making a materially false statement to law enforcement (Count Four). By the time the second superseding indictment was returned, all nine of Hillis’s alleged co-conspirators charged in previous indictments had pled guilty to Count One (or a lesser included charge) pursuant to a plea agreement.

Prior to trial, Hillis filed a motion in limine seeking to exclude summary records of pseudoephedrine transactions from seven pharmacies that identified Hillis as the purchaser by name, address, and driver’s license number. Each of the seven pharmacy records included a certificate of authentication from a records custodian. Relying on United States v. Towns, 718 F.3d 404 (5th Cir. 2013), the district court denied the motion, finding that the pharmacy records fit within the business-records hearsay exception, Fed. R. Evid. 803(6), and that the admission of the records did not implicate the Confrontation Clause because they were nontestimonial.

At.trial, the government presented witnesses from two of the pharmacies—a loss prevention manager from Walgreens and a *224 pharmacist from Wal-Mart. The witnesses testified that employees selling the pseu-doephedrine are required to obtain photo identification from the customer and compare the photograph to the customer. After obtaining identification, the employees manually key the customer’s name and address into the system, The witnesses also testified about the training each employee received on this process and the consequences of failing to comply, including possible termination and civil fines for pharmacists. The witnesses also explained that in 2011, after Hillis’s involvement in the conspiracy, Tennessee law became stricter by limiting the class of employees authorized to make pseudoephedrine sales. Neither of the witnesses observed the purchases at issue in this case.

Special Agent Stephen Gordy of the ATF testified that pharmacy records of pseudoephedrine purchases are compiled in the Tennessee Meth Information System (TMIS) to allow law enforcement to detect suspicious purchasing of pseu-doephedrine, a necessary ingredient for methamphetamine. The TMIS is often used as a starting point in investigating methamphetamine activity and was one of the primary tools in this investigation. Gordy testified that the pharmacy records reflect Hillis making many pseudoephed-rine purchases at or near the same times and locations as her codefendants, sometimes making multiple pseudoephedrine purchases on the same day. Gordy also compared the pharmacy records with Hil-lis’s bank records to show that approximately ten pseudoephedrine purchases were made with Hillis’s bank card. 1 Gordy further explained that Hillis’s bank card was used in stores near the pharmacies from which pseudoephedrine was purchased by Hillis’s codefendants at around the same time. Gordy concluded that the purchase patterns were consistent with a methamphetamine-manufacturing conspiracy.

Other evidence presented at trial included the testimony of a law-enforcement officer, who described the seizure of methamphetamine-manufacturing equipment and ingredients belonging to codefendants Jeremy Rigsby and Jacob Barnes, which prompted the investigation that led to Hil-lis. In addition, several of Hillis’s codefen-dants testified about Hillis’s involvement in the conspiracy. Rigsby testified that Hillis was his girlfriend on and off during the conspiracy; that he and Hillis purchased pseudoephedrine together on dates reflected in the pharmacy records; that all the pseudoephedrine they purchased was used to make methamphetamine; and that Hillis used methamphetamine with him and helped with some of the prep work to manufacture it. Grant Turner, Rigsby’s brother, similarly testified that Hillis accompanied him to purchase pseudoephed-rine used to make methamphetamine and that Hillis had helped with prep work at her apartment. Lori Cope testified that she used methamphetamine with Hillis around 2008. Gabriel Womack testified that Hillis traded pseudoephedrine pills for methamphetamine that Womack manufactured.

After the government rested, Hillis testified that she had suffered from allergies or sinus issues since she was a child, which she treated with regular use of pseu-doephedrine. 2 Hillis also testified that she almost always used her bank card when she made purchases. She admitted that *225 she purchased the pseudoephedrine when the records reflected that her bank card was used, but denied that she made any of the other pseudoephedrine purchases reflected in the pharmacy records. To explain those non-bank card purchases, she testified that she lost her driver’s license in October 2000 and had it replaced. Then, a couple of weeks later, she found the lost license so she had an extra driver’s license. Hillis testified that she dated Rigsby from 2001 or 2002 until 2005 or 2006, and that Rigsby was aware of her extra license. According to' Hillis, Rigsby took her license and gave it to Cope and another woman to use to purchase pseudoephed-rine. When confronted "with records showing that she made purchases with her bank card minutes apart from codefendants’ purchases at the same store, or that she used her bank card in stores in the same city at approximately the same time her driver’s license was being used to purchase pseudoephedrine, Hillis agreed with the government that these occurrences were the result of a “terrible coincidence.” (R. 481: Trial Tr„ PID 2032-40.)

The jury returned guilty verdicts on Counts 1 and 2. 3

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hillis v. United States
E.D. Tennessee, 2020
United States v. Malik Farrad
895 F.3d 859 (Sixth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
656 F. App'x 222, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-betsy-hillis-ca6-2016.